These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 31845776)

  • 1. Cirrhosis: Diagnosis and Management.
    Smith A; Baumgartner K; Bositis C
    Am Fam Physician; 2019 Dec; 100(12):759-770. PubMed ID: 31845776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cirrhosis: diagnosis, management, and prevention.
    Starr SP; Raines D
    Am Fam Physician; 2011 Dec; 84(12):1353-9. PubMed ID: 22230269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver Disease: Cirrhosis.
    Baumgartner K; Cooper J; Smith A; St Louis J
    FP Essent; 2021 Dec; 511():36-43. PubMed ID: 34855340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver fibrosis in non-alcoholic fatty liver disease - diagnostic challenge with prognostic significance.
    Stål P
    World J Gastroenterol; 2015 Oct; 21(39):11077-87. PubMed ID: 26494963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and Evaluation of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Including Noninvasive Biomarkers and Transient Elastography.
    Tsai E; Lee TP
    Clin Liver Dis; 2018 Feb; 22(1):73-92. PubMed ID: 29128062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of Nonalcoholic Steatohepatitis-Associated Cirrhosis in the United States: An Analysis of National Health and Nutrition Examination Survey Data.
    Kabbany MN; Conjeevaram Selvakumar PK; Watt K; Lopez R; Akras Z; Zein N; Carey W; Alkhouri N
    Am J Gastroenterol; 2017 Apr; 112(4):581-587. PubMed ID: 28195177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current complications and challenges in nonalcoholic steatohepatitis screening and diagnosis.
    Golabi P; Sayiner M; Fazel Y; Koenig A; Henry L; Younossi ZM
    Expert Rev Gastroenterol Hepatol; 2016; 10(1):63-71. PubMed ID: 26469309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detecting patients with cirrhosis in primary care.
    Keane MG; Lai C; Pereira SP
    Practitioner; 2014; 258(1773):15-20, 2-3. PubMed ID: 25211789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective noninvasive analysis of hepatic fibrosis in patients with Crohn's disease: correlation of transient elastography and laboratory-based markers.
    Brühl J; Schirren M; Wei C; Antoni C; Böcker U
    Eur J Gastroenterol Hepatol; 2011 Oct; 23(10):923-30. PubMed ID: 21814142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comprehensive review of noninvasive liver fibrosis tests in pediatric nonalcoholic Fatty liver disease.
    Mansoor S; Collyer E; Alkhouri N
    Curr Gastroenterol Rep; 2015 Jun; 17(6):23. PubMed ID: 26031832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cirrhosis and chronic liver failure: part I. Diagnosis and evaluation.
    Heidelbaugh JJ; Bruderly M
    Am Fam Physician; 2006 Sep; 74(5):756-62. PubMed ID: 16970019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study.
    Vilar-Gomez E; Calzadilla-Bertot L; Wai-Sun Wong V; Castellanos M; Aller-de la Fuente R; Metwally M; Eslam M; Gonzalez-Fabian L; Alvarez-Quiñones Sanz M; Conde-Martin AF; De Boer B; McLeod D; Hung Chan AW; Chalasani N; George J; Adams LA; Romero-Gomez M
    Gastroenterology; 2018 Aug; 155(2):443-457.e17. PubMed ID: 29733831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peculiarities of Cirrhosis due to Nonalcoholic Steatohepatitis (NASH).
    El-Sherif O; Armstrong MJ
    Semin Liver Dis; 2020 Feb; 40(1):1-10. PubMed ID: 31537030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving the identification and monitoring of cirrhosis.
    Keane MG; Hensher C; Pereira SP
    Practitioner; 2016 Nov; 260(1798):25-9. PubMed ID: 28968053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The evaluation of hepatic fibrosis scores in children with nonalcoholic fatty liver disease.
    Mansoor S; Yerian L; Kohli R; Xanthakos S; Angulo P; Ling S; Lopez R; Christine CK; Feldstein AE; Alkhouri N
    Dig Dis Sci; 2015 May; 60(5):1440-7. PubMed ID: 25540086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration.
    Patel YA; Gifford EJ; Glass LM; Turner MJ; Han B; Moylan CA; Choi S; Suzuki A; Provenzale D; Hunt CM
    Dig Dis Sci; 2018 Sep; 63(9):2259-2266. PubMed ID: 29779083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrosis Assessment in Nonalcoholic Fatty Liver Disease (NAFLD) in 2016.
    Kaswala DH; Lai M; Afdhal NH
    Dig Dis Sci; 2016 May; 61(5):1356-64. PubMed ID: 27017224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Management of compensated liver cirrhosis 2018 - Evidence based prophylactic measures].
    Karkmann K; Piecha F; Rünzi AC; Schulz L; von Wulffen M; Benten D; Kluwe J; Wege H
    Z Gastroenterol; 2018 Jan; 56(1):55-69. PubMed ID: 29316579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different patterns of decompensation in patients with alcoholic vs. non-alcoholic liver cirrhosis.
    Wiegand J; Kühne M; Pradat P; Mössner J; Trepo C; Tillmann HL
    Aliment Pharmacol Ther; 2012 Jun; 35(12):1443-50. PubMed ID: 22530565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Liver Cirrhosis].
    Brenig R; Bernsmeier C
    Praxis (Bern 1994); 2023 Sep; 112(11):554-561. PubMed ID: 37823811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.